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Background: Reverse transcriptase (RT) converts the
single-stranded RNA genome of a retrovirus into a dou-
ble-stranded DNA copy for integration into the host
genome. This process requires ribonuclease H as well as
RNA- and DNA-directed DNA polymerase activities.
Although the overall organization of HIV-1 RT is
known from previously reported crystal structures, no
structure of a complex including a metal ion, which is
essential for its catalytic activity, has been reported.
Results: Here we describe the structures at 1.8 A resolu-
tion of a catalytically active fragment of RT from
Moloney murine leukemia virus (MMLV) and at 2.6 A of
a complex of this fragment with Mn2+ coordinated in
the polymerase active site. On the basis of similarities
with HIV-1 RT and rat DNA polymerase 3, we have
modeled template/primer and deoxyribonucleoside
5'-triphosphate substrates into the MMLV RT structure.
Conclusions: Our model, in the context of the disposi-
tion of evolutionarily conserved residues seen here at high
resolution, provides new insights into the mechanisms of
catalysis, fidelity, processivity and discrimination between
deoxyribose and ribose nucleotides.
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Introduction
Reverse transcriptases (RTs) are encoded by all retro-
viruses and play a defining role in the retroviral life cycle
[1,2]. These enzymes couple DNA-directed and RNA-
directed polymerase activities with a ribonuclease
(RNase) H activity to make a double-stranded DNA
copy of the single-stranded RNA genome of the retro-
virus [3,4], which is then integrated into the host
genome by the retroviral integrase. Genetic and bio-
chemical characterizations have been made for various
RTs, particularly for Moloney murine leukemia virus
(MMLV), Rous sarcoma virus (RSV) and HIV-1. In spite
of their relative simplicity, lacking the associated compo-
nents of conventional replicative polymerases, the RT
enzymes are very effective. They are highly processive,
making many primer extensions without dissociation of
the template. They copy the template with rather good
intrinsic fidelity (error rates of 1 in 104-106) [5], but in
the absence of editing machinery this leads to a mutabil-
ity that is exploited to escape immune defenses. They
also incorporate deoxyribonucleotides to the exclusion
of their ribose counterparts. While these properties have
been characterized, the underlying molecular mecha-
nisms are not understood. On the basis of analogies with
other systems, a two-metal mechanism for catalysis has
been proposed, but structural details have not been
described for RT [6-8]. Because of its critical role in
infection, the RT of HIV-1 has become one of the
targets of drug therapy efforts against AIDS. In fact,
the drugs currently available for treatment of patients
with AIDS include 3'-azido-3'-deoxythymidine (AZT),
2',3'-dideoxyinosine (ddI), 2',3'-dideoxycytidine (ddC)
and 2',3'-didehydro-2',3'-dideoxythymidine (4dT), which
all act by inhibiting HIV-1 RT [9]. These drugs, how-
ever, have not been satisfactory in preventing the pro-
gression of AIDS. Drug-resistant strains of HIV-1 emerge
that are found to have mutations in RT [9].
Murine, avian, and human retroviruses produce RTs that
differ in size and subunit structure [3]. Murine retroviral
RT is a monomer as isolated from MMLV with a molec-
ular weight of 75 kDa [10]. It has been suggested that
this enzyme may be homodimeric in the presence of
substrate [11]. Avian and human retroviral enzymes are
both heterodimers. The human retroviral RT from HIV
consists of 66 kDa (p66) and 51 kDa (p51) subunits. The
smaller subunit results from retroviral proteolytic removal
of the RNase H domain from the p66 subunit. Both
subunits contain four domains denoted fingers, palm,
thumb and connection. The naming of the first three
domains refers to their resemblance to a right-hand as
first described in the structure of the Klenow fragment
from Escherichia coli DNA polymerase [12]. Avian retrovi-
ral RT from RSV comprises a 95 kDa and a 63 kDa sub-
unit, the latter being a processed version of the former. It
retains an integrase domain as part of the RT on the
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larger subunit [13,14]. In spite of architectural differ-
ences, retroviral RTs are homologous proteins with
highly conserved motifs [15-18] and overall sequence
identities at the level of 25%.
The structure of HIV-1 RT has now been reported in
five distinctly different crystal lattices. The first was
reported by Kohlstaedt et al. [19] in a complex with the
non-nucleoside inhibitor (NNI) nevirapine at 3.5 A
(later refined at 2.9 A resolution [20]). This revealed an
asymmetrical arrangement of the p66 and p51 subunits.
Although corresponding domains in p66 and p51 are
similar in structure, the tertiary structure of p51 is signifi-
cantly different from that of p66. In this same crystal lat-
tice, two additional NNI complexes, a 2.8 A resolution
complex with ot-anilinophenylacetamide (ot-APA) [21]
and a 3.0 A resolution complex with tetrahydroimidazo-
(4,5,1-1-jk)(1,4)-benzodiazepin-2(1 H)-one (TIBO) [22]
have been reported. The second distinct crystal lattice
reported was a complex with Fab and a 19/18mer
oligonucleotide at 3.0 A resolution [23]. A third distinct
lattice co-crystallized with nevirapine was described at
4.2 A [24]. More recently, a fourth lattice was reported
for an unliganded state at 3.2 A resolution [25]. The fifth
distinct lattice has been reported for four structures of
complexes with NNIs [26] described at 2.2-3.0 A and a
2.35 A unliganded state [27]. In addition, Unge et al. [28]
have reported the 2.2 A resolution structure of the
N-terminal fragment of HIV-1 RT (residues 1-216).
The 1-216 fragment includes the fingers domain and a
truncated palm domain lacking three 13 strands [28].
We have focused structural investigations on MMLV RT
in the hope that insights gained from comparing con-
served features among different RTs will help in elucidat-
ing fundamental mechanisms, and that ultimately, this
may lead to the design of more effective drugs for the
treatment of AIDS. In order to enhance our understand-
ing of the enzymatic mechanism of RTs, we have con-
centrated on obtaining results at high resolution. Here
we report the structure at 1.8 A of a polymerase catalytic
fragment (produced by limited proteolysis with trypsin),
which includes the fingers and palm domains of MMLV
RT (residues 10-278 of the 671 present in the whole
molecule). This fragment is catalytically active in standard
RT assays [11], although its activity is substantially
reduced (-6000-fold) relative to the whole molecule
(M Georgiadis, unpublished data). The fragment also
binds oligonucleotides, again more weakly than the
whole enzyme. In gel shift assays, the fragment displays a
preference for double-stranded oligonucleotides with a
single-strand overhang as opposed to blunt-ended
oligonucleotides (M Georgiadis, unpublished data). We
conclude that the essential catalytic machinery is intact as
the observed activity is qualitatively explained by defects
in binding and processivity.
The crystal structure of this catalytic fragment is at suffi-
ciently high resolution to provide reliably defined details
of polypeptide conformations and solvent interactions in
the active site. In addition, we have determined the
structure of a complex with a metal ion at 2.6 A resolu-
tion, which locates the metal ion in the catalytic site as
required for polymerase activity. Comparison of this
structure from MMLV RT with the corresponding por-
tions of HIV-1 RT structures shows that significant dif-
ferences exist but that many features are conserved. To
help in understanding the roles of conserved residues, we
have constructed a conservative model of the ternary
complex with oligonucleotide and deoxyribonucleoside
5'-triphosphate (dNTP) substrates on the basis of super-
positions with the HIV-1 RT/DNA complex structure
[23] and the rat DNA polymerase P3 ternary complex
structure [8]. The structural comparisons, together with
this model of the ternary complex, generate specific
hypotheses about the roles of conserved residues and cer-
tain mechanistic aspects of processivity, fidelity, and the
incorporation of dNTPs in preference to ribonucleotides
(NTPs). Many of these findings are of general signifi-
cance for other enzymes that have polymerase activities.
Results and discussion
Structure description
The structural model was interpreted from a combined
multiwavelength anomalous dispersion (MAD) and single
isomorphous replacement with anomalous scattering
(SIRAS) phased electron-density map at 2.5 A resolution
and refined at 1.8 A to an R-value of 0.197 for all data as
detailed in the Materials and methods section. The
experimental electron-density map and the corresponding
1.8 A 2F -F c map are shown for the polymerase active
site region of the molecule in Figure 1. The structure
consists of two domains, fingers and palm, both of which
exhibit a+3 folds as seen in Figure 2. The nomenclature
for secondary structural elements is as follows: a helices
have letters assigned alphabetically from the N terminus
of the molecule to the C terminus and strands have
been numbered sequentially from the N to the C termi-
nus. Corresponding secondary structural elements in the
HIV-1 RT model [27] and our model do not have the
same letter or number because our structure includes
additional elements not found in the HIV-1 RT model.
The fingers domain contains a highly twisted five-
stranded mixed sheet comprising strands 32, 33, 134, 8
and 139. This sheet is partly defined on topological
grounds because only one main-chain hydrogen bond
exists between strands 134 and g38 in the middle of the
sheet instead of the usual two or more main-chain
hydrogen bonds. Additional secondary structural ele-
ments in the fingers include three ao helices: ac (which is
bent in our structure due to the presence of Pro76 in the
middle of the helix), aD and aG (which is a 310 helix).
Helix aol in the HIV-1 RT structures, which is equiva-
lent to our atc, does not contain a proline and is not
bent. There are also two hairpin structures, 38-139,
which is part of the sheet, and 134-135. The main-chain
hydrogen-bonding pattern for the 34-35 hairpin is bro-
ken before the poorly ordered [34-135 loop.
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Fig. 1. Electron density distributions sur-
rounding the polymerase active site in
MMLV RT. (a) The experimental elec-
tron-density map using the combined
MAD and SIRAS phasing to 2.5 A shown
superimposed on the refined model. (b)
Refined 2Fo-F c map at 1.8 A shown
superimposed on the refined model.
Contour levels are 1.2a for the experi-
mental map and 1a for the 2F_-F c map.
The view includes (from left to right)
strands 10, l311 and 7.
Fig. 2. The core fragment of MMLV RT. (a) Schematic ribbon diagram showing a helices in purple (labeled A-i) and l3 strands in green
(labeled 1-14). (Drawn with MOLSCRIPT [60].) (b) Stereo drawing of the Ca backbone including residues 24-274. Every twentieth
residue has been numbered, starting with residue 30, and is represented by an enlarged sphere at the Ca position. (Produced with
PLUTO implemented in the CCP4 software package 150].)
The palm domain contains a four-stranded antiparallel
P sheet (P7, 31O, 311 and [12) and two long a helices
(aH and al) which define the core of this domain. Addi-
tionally, it contains a [3 hairpin including strands P13 and
P14 at the C terminus of the molecule, denoted the
primer-grip [23], two short N-terminal a helices (aA
and aB), a short 3 10 helix (F) leading into the fingers
domain, and one additional short a helix (aE). The regu-
lar a-helical hydrogen-bonding pattern is broken in aH.
For two pairs of main-chain hydrogen bonds (i.e.
between residues 205-209 and 206-210) a water mol-
ecule intervenes between the carbonyl oxygen and amide
nitrogen atoms of each pair to create a bend in H. Fig-
ure 3 details the residues comprising the secondary struc-
ture in a structural alignment of the fingers and palm
domains of HIV-1 RT and MMLV RT.
The two domains of the catalytic fragment are struc-
turally integrated such that the boundaries between
them blur. The chain originates and ends in the palm
domain (lower portion in Fig. 2) and makes two passages
into and back from the fingers domain (upper portion in
Fig. 2), aB-3 1, aD-P 6, aF-°G and P9-aH. The inter-
face between the fingers and palm domains, which
includes the connecting segments, contains conserved
elements that are crucial for function and others needed
to maintain the fold as discussed below. The approxi-
mate domain boundaries for fingers and palm domains
are as follows: fingers 41-124 and 159-194, palm 24-40,
125-158 and 195-274.
Several conserved residues (see Fig. 3) are involved in
main-chain hydrogen-bonding interactions which prob-
ably stabilize the structure. These residues include Lys53,
Gln63, Ser195 and Gln260. The N atom of Lys53
forms a hydrogen bond to the main-chain carbonyl oxy-
gen of Lysl20 of atD. The side-chain hydroxyl of Ser195
is hydrogen bonded to the main-chain carbonyl oxygen
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Fig. 3. Sequence alignment of residues 1-274 of MMLV RT and 1-235 of HIV-1 RT. The alignment is based on a Ca superposition of
the structural models. Secondary structural elements for MMLV RT and the 2.35 A unliganded HIV-1 RT [27] structures found in the
palm are shaded gray; those in the fingers are boxed and unshaded. Underlined for HIV-1 RT are the sequence and corresponding sec-
ondary structural elements assigned in [23]. Residues conserved in the avian, human and murine RTs, based on our sequence align-
ments, are in bold text. Vertical lines indicate identical residues, two dots indicate very similar residues, and one dot indicates
somewhat similar residues in MMLV and HIV-1 sequences. The larger gray boxes encompassing both sequences are the residues used
in the superposition analysis.
of Pro189, which is part of a highly conserved loop in
the interface between the fingers and palm domains.
Gln63 NE and OE atoms form two hydrogen bonds
with the main-chain atoms of Lys98 thereby hydrogen
bonding 32 to 134 in the 13 sheet of the fingers domain.
A similar hydrogen-bonding arrangement exists for
Gln260 and Lys267, between which residues there are
two hydrogen bonds connecting 1312 and P131, which are
part of the primer-grip. All of these interactions appear
to have structural roles in our model and these are pre-
sumably important because these residues are conserved
in the RT family.
Comparison with the RNP motif
The ribonucleoprotein (RNP) motif is an RNA-binding
domain found in a number of proteins that mediate pro-
cessing of RNAs (for review, see [29]). RNP motifs,
comprising 90-100 amino acids, are the only RNA-
binding domains for which detailed structural informa-
tion is available. The crystal structure of U1 small nuclear
ribonucleoprotein (snRNP) A revealed that it has a
13oat13 motif that makes up a four-stranded antiparallel
13 sheet with two flanking helices [30]. The sheet is
antiparallel but each 13ot13 unit has a classic right-handed
conformation. This has also been shown to be the struc-
ture for a human heterogeneous nuclear RNP [31], and
the same topology is found in several other proteins, as
noted by Cheah et al. [32].
We noticed, as did Unge et al. [28], that the topology of
the palm domain is identical to the topology of the RNP
motif and have now compared the structures by CaL
superposition. As shown in Figure 4, the structures of the
palm domain and the RNP motif are not identical but
are strikingly similar. We suggest that the fingers domain
could be considered to result from a series of insertions in
the palm domain and that the palm domain may in fact
be evolutionarily related to the RNP motif. RNPs con-
tain two highly conserved binding motifs, RNP1 and
RNP2, that correspond to the secondary structural ele-
ments 131 and 133 of the RNP motif. Corresponding
strands from MMLV RT would be 137 and 311 (34 and
18 in HIV-1 RT; see Fig. 3) in the palm domain. Very
little sequence similarity exists between 17 and RNP1
and even less between 131 and RNP2 that has been
modified to include a polymerase active site.
The fold shared by the palm domain of RTs and RNA-
binding proteins may provide a general nucleic acid bind-
ing domain that has been utilized by a number of
different proteins including DNA polymerase from E. coli
[12] and T7 RNA polymerase [33]. Both of these poly-
merases have palm domains similar to that found in RT,
but the fingers domains are more variable. Moreover, the
recent structure of an RNA complex with U1 snRNP
[34] shows that RNA binding occurs on the same surface
of the RNP as that used for nucleic acid binding by the
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Fig. 4. Comparison of the RNP motif with
the fingers and palm domains of MMLV
RT and Klenow fragment based on Ca
positions. Superimposed Ca traces are
shown in stereo with the U1 snRNP
domain in blue, the MMLV RT core frag-
ment in green and the Klenow fragment
fingers and palm domains in magenta.
(Superpositions and stereo drawings
were generated using INSIGHT [391.)
polymerases. Rat DNA polymerase 3, however, does not
have a Po3PP3ot folding motif [35].
Comparison with HIV-1 RT
We have compared our structure of fingers and palm
domains to those found in five models for HIV-1 RT
[20,23,25,27,28]. The overall fold and structures of these
two domains in our protein are very similar to that
described in the HIV-1 RT structures with a few excep-
tions. The MMLV RT sequence includes an additional
N-terminal 40 amino acids not present in the HIV-1 RT
sequence, as predicted using GCG [36] sequence align-
ments. Our structural model includes 16 ordered residues
not present in the HIV-1 RT structure. The consequence
of these additional residues is that, in contrast to the
HIV-1 RT, which has its N terminus in the fingers
domain, the MMLV RT fold starts in the palm domain.
The overall sequence identity for the two RTs is 24.8%.
If just the fingers and palm domains are compared, the
sequence identity is 28.7%. We conclude, therefore, that
these two domains are not appreciably more related than
the other domains in the protein.
We have aligned the sequences of MMLV RT and HIV-1
RT, as shown in Figure 3, based on superposition analysis
restricting insertions and deletions between elements of
secondary structure. The sequence identity based on our
alignment is 26.0%. We have also compared the sec-
ondary structure in the two molecules using the 2.35 A
unliganded HIV-1 RT [27] for comparison. The assign-
ment of secondary structure for both models has been
performed using Kabsch and Sander's algorithm [37].
Many of the secondary structural elements are present in
both structures. Our structure includes three additional
a helices and three strands not present in the HIV-1 RT
structure (A, tB, aE, 31, P 6 and 1312)
.
We have also
identified helices F and aG as 310 helices, which corre-
spond to a3 and a4 in the HIV-1 RT model. The struc-
tural alignment (see Fig. 3) of these sequences summarizes
the similar and dissimilar structural elements for the fin-
gers and palm domains of these two RTs and provides a
more accurate correspondence of the linear sequences
than can be obtained by sequence information alone.
We have further characterized the differences between
the HIV-1 and MMLV RTs by superimposing Co posi-
tions from the fingers and palm domains of the p66 sub-
unit of HIV-1 RT on the MMLV RT fingers and palm
domains. The individual palm (see Fig. 5) and fingers
domains superimpose with root mean square deviations
(rmsds) of 0.6-1.4 A for the various models, as shown in
Table 1. However, superposition of both domains simul-
taneously results in much larger rmsds, indicating shifts of
one domain relative to the other in the various models,
as discussed below. Superpositions were performed using
TOSS [38] and INSIGHT [39]. We also note that in a
superposition including the full HIV-1 RT molecule, the
region of our structure between 36 and aE is brought
into very close contact with residues 136-142 from p51.
This implies that dimerization of MMLV RT would
require an altered interface or a conformational change
in order to accommodate the dimer interface observed in
the HIV-1 RT structures.
In order to describe the orientation of the fingers
domains with respect to the palm domains, we have used
Cot coordinates for palm domains previously superim-
posed and then superimposed the fingers domains in
TOSS [38] to give a relative angle and translation
between two fingers domains. The results (Table 1) indi-
cate that small differences exist in the relative angles and
translations in all of the structures compared. Relative
angles and translations are given for p66 versus p51 for
comparison. These relative shifts have very small effects
on the interface between the two domains with the
exception of the truncated (1-216) HIV-1 RT model
[28], which has a substantial shift of the fingers domain
into the interface. Missing strands in the palm domain of
the 1-216 model may account for this altered interface.
The additional N-terminal 16 residues found in MMLV
RT change the size of the interface between the fingers
and palm domains, which is the most notable difference
in the comparison with HIV-1 RT (see Fig. 5). The fact
that the fingers and palm domains in MMLV RT are
resistant to proteolytic degradation is consistent with the
notion that these two domains form a relatively rigid unit
within the molecule. It has been noted by others
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Fig. 5. Comparison of MMLV RT and
HIV-1 RT fingers and palm domains.
Stereo superimpositions were based on
the Cac coordinates of the palm domains
of MMLV RT and unliganded HIV-1 RT
[27]. Ca traces are shown for the fingers
and palm domains for MMLV RT (green)
and unliganded HIV-1 RT (red).
[21,24,25], that when different structural models of
HIV-1 RT are superimposed, the fingers and palm
domains of the p66 subunit behave approximately as a
rigid unit when compared with the other domains in the
enzyme. This is consistent with our finding in comparing
the catalytic fragment of MMLV RT with HIV-1 RT.
Polymerase active site and metal binding
The polymerase active site is located at the junction of the
fingers and palm domains and includes three highly con-
served aspartate residues (150, 224 and 225) that are
required for polymerase activity [40-42]. Each of the
aspartate carboxylate oxygen atoms forms a hydrogen
bond to a water molecule, which in turn is hydrogen
bonded directly to another water molecule, to a main-
chain amide nitrogen atom, or to a carbonyl oxygen
atom, resulting in an extensive network of water mole-
cules (see Fig. 6a). Both Asp224 and Asp225 have one
carboxylate oxygen atom within hydrogen-bonding dis-
tance of the same water molecule. However, a hydrogen
bond with the carboxylate oxygen from Asp224 is not
directionally favorable. The remaining carboxylate oxygen
atoms from Asp224 and Asp225 are linked in a hydrogen-
bonding network through two water molecules.
Table 1. Ca superpositions using TOSS [38].
Domain Residue numbers Number of Models* Rmsd Relative Relative
Cc atoms rotationt translationt
MMLV HIV
Palm 145-152 105-112 mmlv/dnafab 1.16A
196-212 157-173 mmlv/nev 1.18 A
217-231 178-192 dnafab/nev 1.02 A
233-249 195-211 57 mmlv/apo_2.35 1.21 A
mmlv/apo_3.2 1.03 A
apo_2.35/216 0.57 A
mmlv/216 1.15 A
hiv66/51 1.18 A
Fingers 58-64 18-24 mmlv/dnafab 1.37 A 8.61° 0.098 A
68-85 28-45 mmlv/nev 1.39 A 7.470 -0.004 A
95-102 57-64 dnafab/nev 1.27 A 2.21 1.46 A
110-122 72-84 mmlv/apo_2.35 1.15A 12.51° 1.61 A
168-172 128-132 mmlv/apo_3.2 1.19 A 7.170 0.86 A
182-186 143-147 56 apo_2.35/216 0.95 A 14.250 0.71 A
mmlv/216 1.09 A 15.13 ° 0.13 A
hiv66/51 0.62 A 56.47° 1.43 A
*Models are as follows: mmlv, MMLV RT core fragment model; dnafab, HIV-1 RT Ca coordinates [23] (PDB entry 1 HMI); nev,
HIV-1 RT model with nevirapine [20] (PDB entry 3HVT); apo_3.2, HIV-1 RT unliganded model [25] (PDB entry 1 HMV); apo_2.35,
HIV-1 RT unliganded Ca coordinates [27] (obtained from D Stuart), and 216, HIV-1 RT truncated Ca coordinates [28] (obtained
from B Strandberg). The p66 and p51 coordinates are taken from the apo_2.35 model. tThe relative rotations and translations for
superpositions of the fingers domains are defined by starting with Ca coordinates already transformed by superpositions of palm
domain residues. We note that the relative angle of rotation is sensitive to the relative translation.
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Fig. 6. Atomic model of the active site of
MMLV RT and metal-binding site. (a) A
ball-and-stick stereo diagram of the
active site including the highly con-
served aspartate residues 150, 224 and
225. Water molecules are shown as
enlarged spheres and hydrogen bonds
are shown as dashed lines. (Drawn with
PLUTO [50].) (b) A stereoview similar
to that in (a) is shown for a metal-bind-
ing experiment. A difference Fourier
map (shown in blue) resulting from data
collected with Mn2+ bound in the crys-
tal is shown superimposed on the
refined native (green) and metal-com-
plexed (red) models. The contour level
shown for the map is 4a.
We had originally hypothesized that metal ions, either
magnesium or manganese [10], which are required for
polymerase activity, would replace water molecules in the
active site. We report here the first complex for an RT
containing a metal ion. We find one Mn2+ bound in the
polymerase active site coordinated to Asp224 and Asp225
and replacing a water molecule (see Fig. 6b). The experi-
mental difference density for the metal site is significantly
elongated, indicating anisotropic disorder of the metal site
(see the Materials and methods section). This disorder is
probably due to the incomplete coordination sphere
observed for the metal site, which has two carboxylate
oxygen ligands from Asp225 and one from Asp224. The
nearest oxygen ligand from Asp150 is 3.5 A away (if the
metal ion is placed in the center of the difference electron
density) and is not a likely ligand. We have not deter-
mined water coordination to this metal ion conclusively,
but find evidence for no more than two potential coordi-
nating water molecules (see the Materials and methods
section). As shown in Figure 6b, the protein structure in
the polymerase active site is perturbed very little by the
binding of one metal ion, with only slight changes in the
positions of Asp224, Asp225 and Asp150. However, the
water structure in the active site has been perturbed rela-
tive to the native structure. Presumably, the coordination
sphere of the metal ion is completed by the binding of
substrate. These results support the existence of a pre-
formed metal-binding site involving Asp224 and Asp225.
Consistent with a previous report describing metal ion
binding in rat polymerase 3 [43], a single metal site is
found in the active site of MMLV RT in the absence of
bound nucleotide. Mn2 + in this site would be responsible
for assisting deprotonation of the ribose 3'-hydroxyl in
order to facilitate nucleophilic attack on the a phosphate
of the dNTP according to the proposed mechanisms of
polymerization [6,8]. We do, however, expect differences
in detail for the disposition of active-site groups between
the rat polymerase 3 and MMLV RT structures. These
two enzymes, although they are both polymerases, have
substantially different structures and functional activities.
The 1o-11 turn in our structure is a type II' turn with
Val223 (=56.3°,*=-103.2 ° ) at position 2 of the turn
(see Fig. 1). The position 2 residue of type II' turns is
more commonly a glycine which, lacking a C3 atom,
avoids close van der Waals contacts with other atoms in
the turn. However, the RT sequences all exhibit a non-
glycine residue in this position. An important conse-
quence of this particular turn is a hydrogen-bonding
interaction between one of the carboxylate oxygen atoms
of Asp224 and its main-chain amide nitrogen atom,
which specifies carboxylate orientation and stabilizes the
tight turn (Fig. 6a). Binding of Mn 2+ in the active site
does not disrupt this hydrogen bond. Type II' turns have
also been described for the equivalent (YXDD) 7-138
turn of HIV-1 RT in recently reported structures of
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unliganded RT at 3.2 A [25] and in both an NNI-RT
complex at 2.2 A [26] and uninhibited RT at 2.35 A
[27]. This turn appears to be very sensitive to changes
that occur elsewhere in the enzyme; it is in a standard
conformation in the prematurely truncated 1-216 frag-
ment of HIV-1 RT [28], and conformations differ
between the uninhibited and inhibited states of intact
HIV-1 RT [21,27] with the carboxylate group of Aspl85
(224 in MMLV RT) projecting out and away in the
inhibited state [26]. Although the hydrogen-bonding
interaction seen here for MMLV RT is not reported for
the active state of HIV-1 RT, published data [27] appear
to be compatible with this conformation. We suggest
that the conformation for this turn and the hydrogen-
bonded specification of the orientation of Asp224
(Aspl85 in HIV-1 RT) may be crucial for the mecha-
nism of polymerization. Additional stabilization of the
type II' turn in our structure is provided by Asp200
which forms a hydrogen bond to the main-chain amide
nitrogen of Val223.
Interaction with template/primer and dNTP
We have modeled the binding of template/primer
A-form DNA and dNTP to the MMLV RT fragment
using previously reported experimental results [8,23].
This modeling was motivated by the similarity described
above between the fingers and palm domains of MMLV
and HIV-1 RT structures and the prospect that func-
tional roles might be deduced for conserved residues, as
accurately defined by this high-resolution structure of
MMLV RT. A-form DNA was selected on the basis of
the experimental results of Jacobo-Molina et al. [23]
who reported the structure of A-form DNA bound in
the polymerase active site of HIV-1 RT. In addition, we
would logically expect an enzyme that can utilize either
a DNA template/DNA primer, which adopts many
helical forms, or an RNA template/DNA primer,
which would most probably have A-form helical para-
meters, to have an active site that would accommodate
an A-form duplex.
Despite the simplicity of our modeling, which involved
direct superposition without further modifications (as
detailed in the Materials and methods section), we find
surprisingly few close contacts. As modeled, close con-
tacts do exist between the phosphate coordinates in the
model dATP and Asp224 and Asp225. Adjustments
would be needed, but in general the model is consistent
with a two-metal mechanism with 3'-hydroxyl activation
as discussed above. On the basis of our ternary model
complex (see Fig. 7a) and an analysis of conserved
residues found in avian, murine and human RTs (Fig. 3),
we propose structural features that are likely to con-
tribute to additional properties of RTs, such as fidelity of
template-directed polymerization and processivity in
replication (defined as the number of nucleotides incor-
porated per cycle of binding, synthesis and dissociation).
We also suggest a structural basis for selectivity by RTs of
dNTPs over NTPs in the active site. RTs incorporate
dNTPs exclusively.
Fidelity of template-directed polymerization
We have identified conserved residues that are likely to be
involved in minor groove hydrogen bonding of the dNTP
and the template base-paired to it, and which may con-
tribute to correct alignment for the nucleotidyl transfer
reaction. We propose that the highly conserved residues
Glnl90 (151 in HIV-1 RT) and Glyl91 (152 in HIV-1
RT) found in the conserved sequence LPQG within loop
9 -aH (part of motif B, a conserved sequence found in
RTs [15-18]), form hydrogen bonds in the minor groove
to 02 or N3 of the dNTP and template base, respectively.
In our ternary model, NE of Gln190 is in an appropriate
position to form a hydrogen bond to N3 of dATP. The
main-chain amide nitrogen of Glyl91 is in approximately
the correct position to form a hydrogen bond to 02, as
shown in Fig. 7b. Upon ternary complex formation, only
very small changes in the exact positioning of the incom-
ing nucleotide and loop P9--OH (6--5 in HIV-1 RT)
relative to our model would be sufficient to form the
Gly191 amide nitrogen to base 02 or N3 hydrogen bond
as proposed. Previously, it was proposed that this loop
interacted only with the template strand [23].
We note that Asn279 in the rat polymerase 13 ternary
complex structure [8], which is 2.96 A from the 02 atom
of ddCTP and has been proposed to hydrogen bond to
the incoming nucleotide, is in a similar position to Gln190
in our model. Thus, this hydrogen-bonding potential has
been conserved in other polymerases. Although Gly191 is
not conserved in the rat polymerase 13 structure, Arg283
guanidino N1ll atom is 3.25 A from the template base N3
and could potentially form a hydrogen bond. Because this
part of the interface between the fingers and palm
domains in RT consists of a loop, Gly191 has probably
been conserved in this position because of its ability to
adopt any (,) angles and therefore make the hydrogen
bond with the template base. Asn279 and Arg283 are part
of an ot helix in rat polymerase 13. Other residues involved
in binding the dNTP and the primer strand in the active
site include the conserved aspartate residues 150, 224 and
225, in addition to Lys258, which we propose binds to
the terminal phosphate in a similar way to Arg149 found
in the rat polymerase 13 ternary complex structure.
The proposed minor groove hydrogen-bonding interac-
tions with N3 or 02 of the template and dNTP provide
a way to position the dNTP and template strand in the
active site without requiring base specificity. As was pre-
viously shown [44], N3 and 02 are equivalent positions
in the minor groove for purine and pyrimidine bases and
provide no distinction between different bases. This type
of interaction is ideal for a polymerase that must have a
way to position all four dNTPs appropriately in order to
catalyze the reaction.
The issue of fidelity concerns not only the ability to posi-
tion substrates correctly for the chemical reaction, but also
the ability to discriminate between correct and incorrect
nucleotides. It seems quite implausible that Watson-Crick
hydrogen bonding and base-stacking interactions alone
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Fig. 7. Interaction between MMLV RT, A-
form DNA and dNTP in the polymerase
active site. (a) The template strand,
primer strand and dNTP are shown in a
stick representation in green, red and
orange, respectively. The MMLV RT core
fragment is represented as a ribbon
schematic with conserved residues (i.e.
those present in avian, human and
murine RTs) shown in ball-and-stick rep-
resentation. The catalytic aspartate
residues 150, 224 and 225 are shown in
yellow. Conserved residues that probably
interact with dNTP and the template base
to which it is hydrogen bonded (colored
magenta) include Gln190, Gly191 and
Lys258. Blue residues are those which
are within 4-5 A of the template/primer
model and which may be involved in
direct or water-mediated hydrogen bond-
ing. (b) A ball-and-stick representation of
the minor groove hydrogen-bonding
interactions and ribonucleotide discrimi-
nation is shown for our ternary complex
model including residues 189-191,
153-156, the incoming nucleotide,
dATP, and the template base dT to which
it is base paired. Pro189 is shown in red,
Gin190 in yellow, Gly191 in blue,
residues 153-156 in magenta, dATP in
orange, and dT in green. A ribose 2'-
hydroxyl group (blue) has been modeled
on the dATP from our ternary complex
model. Hydrogen bonds are shown as
dashed lines between the NE atom of
Gln190 and N3 from dATP, N from
Glyl90.and 02 from the template dT
base paired to dATP, in addition to the
Watson-Crick hydrogen bonds. (Figure
generated using MOLSCRIPT [601.)
would be sufficient for positioning the substrate correctly
for the polymerization reaction. The additional hydro-
gen-bonding interactions in the minor groove are
expected to be more favorable for the incorporation of
the correct nucleotide given that the initial binding
should involve Watson-Crick hydrogen-bonding interac-
tions. Base pairing would then be followed by small con-
formational changes in the 9xH loop and the nucleic
acid allowing the additional hydrogen bonds to form and
position the nucleotide and template correctly for cataly-
sis. We expect that minor groove hydrogen-bonding
interactions may be used by a number of DNA poly-
merases whose abilities to discriminate between correct
and incorrect substrates may be improved by the nature of
the interfaces between the fingers and palm domains.
Conserved residues that are close enough to interact with
the sugar-phosphate backbone of our model DNA include
LyslO3, ArgilO, Aspll4, Argll6, Asnll9, Tyr222,
Gly270 and Tyr271 as shown in Fig. 7a. Tyr222 is located
in the polymerase active site and appears to be within
hydrogen-bonding distance of the N3 or 02 position of
the template base in the duplex portion of the substrate,
which is three bases from the 3'-hydroxyl polymerization
start site. Gly270 and Tyr271 are located in the primer-
grip region and also interact with the primer strand of the
substrate. Residues that interact with the template strand
include LyslO3, Arg1lO and Aspll4. Argll6 and Asnl9
appear to interact with the primer strand. These interac-
tions are probably hydrogen bonds involving direct inter-
action, water-mediated hydrogen bonding, or electrostatic
interactions in the case of charged residues.
Processivity
Conserved aspects of the electrostatic potential surface of
the catalytic fragment suggest that electrostatics may play a
role in processivity. Electrostatic potential surfaces of fin-
gers and palm domains from MMLV RT and HIV-1 RT
[20] are shown in Figure 8. The electrostatic potential
is mapped on the solvent-accessible surface calculated with a
1.4 A probe radius. Full charges for sides chains and partial
charges for main-chain atoms were used assuming a pH of
8. (A comparison with the electrostatic potential surface of
the intact HIV-1 RT reveals no differences for the isolated
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Fig. 8. Electrostatic potential surfaces of
the fingers and palm domains of
(a) MMLV RT and (b) HIV-1 RT [20]
with modeled DNA template/primer.
The surface potentials were calculated
using DELPHI [61] and displayed using
the program GRASP [62]. Purple regions
represent positive, red negative, and
white neutral potential. The modeled
template/primer is represented as a
phosphate backbone ribbon with the
template strand in purple and the primer
strand in red. The large red area near
the 3'-end of the primer strand is the
polymerase active site.
fingers and palm domains.) We note that the overall shapes
of these two domains of the RTs differ from one another.
Conserved features of these surfaces include a highly basic
patch near the primer strand within the fingers domain in
addition to the negatively charged catalytic site. The posi-
tively charged region is not close enough to hydrogen
bond directly to the DNA in our model. We propose that
this region may be involved in electrostatic charge interac-
tions holding the substrate on the enzyme after a dissocia-
tive impulse following the nucleotidyl transfer reaction,
such that the newly incorporated nucleotide 'ratchets' into
the 3' position. A similar metaphor has been invoked by
others [45]. The ratcheting mechanism would involve
repositioning of the template/primer without requiring
product release. We envisage a positively charged 'hook'
on the surface of the fingers domain holding the nucleic
acid on the enzyme by the primer strand while allowing
for repositioning in the active site, thereby promoting pro-
cessivity of polymerization in RT. This interaction would
be only one of several interactions with other domains of
the RT that would be likely to promote processivity.
Selectivity for dNTPs
RTs, like other DNA polymerases, selectively incorpo-
rate dNTPs as opposed to NTPs. Our model suggests
that the structural basis of that selectivity may be an unfa-
vorable interaction between Phe155 and the 2'-hydroxyl
of a ribose nucleotide. The sugar ring of the nucleotide
is approximately stacked over Phe155 as shown in
Figure 7b. The distance between the C2' atom and
Phe155 is 4.5 A in our model, which would bring the
2'-hydroxyl within 3 A of the aromatic ring. However,
we suggest that small conformational changes would pro-
duce unfavorably close interactions and thus discriminate
between ribose and deoxyribose sugars in nucleotides.
Although Phe155 is not absolutely conserved, the only
other residue found in this position in other RTs is
tyrosine, which would serve this purpose equally well.
creation of a double-stranded DNA copy of a sin-
gle-stranded retroviral RNA genome. This double-
stranded DNA copy is then integrated into the
host genome by the retroviral integrase. Several
crystal structures of the HIV-1 RT have been
reported. We report the first structure of a cat-
alytic fragment of the related Moloney murine
leukemia virus (MMLV) RT at 1.8 A resolution. In
addition, we report the first complex of RT
containing a metal ion. One Mn2 + is coordinated
in the polymerase active site to an apparently
preformed metal ion binding site.
Structural comparison of functionally similar RTs
and modeling studies with template/primer and
deoxyribonucleotide substrates in MMLV RT, on
the basis of similarities with rat DNA polymerase
P and HIV-1 RT, have provided us with new
insights into some aspects of the polymerization
reaction accomplished by RT. These include the
catalytic nucleotidyl transfer reaction, fidelity of
nucleotide incorporation, processivity, and dis-
crimination between deoxyribonucleotide and
ribonucleotide substrates.
In addition, we now have a structural (and there-
fore, more accurate) alignment of the sequences of
MMLV and HIV-1 RT. Several of the drug-resistant
mutations in HIV-1 RT are found in MMLV RT as
the native sequence; for example, Leu74-Val [46]
and Metl84-Val [47] which confer resistance of
HIV-1 RT to dideoxyinosine and dideoxycytidine,
respectively. Thus, the structure of MMLV RT may
provide a model for understanding mutations in
HIV-1 RT associated with nucleoside analog resis-
tance found in clinical isolates. In addition, drug
design could be facilitated by targeting conserved
regions of the protein and testing for a drug's abil-
ity to inhibit MMLV RT as well as HIV-1 RT.
Biological implications
Reverse transcriptase (RT) plays a crucial role in
the replication of a retrovirus. DNA- and RNA-
directed DNA polymerase and ribonuclease H
activities associated with RT are responsible for the
Materials and methods
Preparation of proteolytic fragment
We originally attempted to crystallize the whole MMLV RT
enzyme as well as a truncated form lacking the RNase H
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domain. MMLV RT enzymes were expressed in E. coli from
vectors constructed by Telesnitsky and co-workers [11,49] and
purified by a modification (M Georgiadis, unpublished data)
of previously described protocols [48]. Small crystals were
obtained for both of these enzymes. Despite efforts to improve
the crystals by seeding and complexation with oligonu-
cleotides, tRNA, metals and nucleotides, the best crystals dif-
fracted to 6 A. We therefore explored limited proteolysis in
order to define domain boundaries in the protein, which
would allow us to obtain a molecule that might.prove more
suitable for X-ray diffraction studies.
A number of proteolytic enzymes cleaved MMLV RT leaving
a stable 30 kDa fragment (M Georgiadis, unpublished data).
The proteolytic fragment that we characterized resulted from
trypsin cleavage of a truncated form of the enzyme including
amino acids 1-497, which lacks the RNase H domain [11].
N-terminal sequencing identified the N terminus of our frag-
ment as residue 10. Electrospray ionization mass spectrometry
analysis indicated that the C terminus is a mixture terminating
at either residue 274 or 278. This fragment includes fingers and
palm domains of the RT. The details of the proteolysis, purifi-
cation and crystallizations will be described elsewhere.
Structure determination
Crystals of the polymerase catalytic fragment of MMLV RT
were grown by the hanging-drop vapor-diffusion method at
20°C. Drops contained equal volumes of reservoir solution and
approximately 40 mg ml-1 protein in 50 mM 2-[N-mor-
pholino]ethanesulphonic acid pH 6.0, 0.25 M NaCl and 1 mM
dithiothreitol. The reservoir solutions contained 50 mM Tris
pH 7.5, 0.2 M NH4C1 and 20% polyethylene glycol 4000.
Microseeding was required in order to grow single crystals of
suitable size for the structure determination. The crystals proved
to belong to space group P3221 and have cell constants
a=b=84.08 A, c=73.97 A, ot==90° , y=120° with one mole-
cule in the asymmetric unit. Soaking crystals in 2.5 mM mer-
curic acetate produced a three-site derivative solved by Patterson
methods from data recorded on two Hamlin-Xuong area detec-
tors. Area detector data were integrated using the UCSD soft-
ware package [49] and scaled using CCP4 [50]. MAD and
SIRAS phasing methods were used to solve the structure.
The MAD experiment was conducted at the NSLS, HHMI
X4A beamline, on mercuric acetate derivatized crystals. Focus-
ing of a 2 mrad swathe of radiation was accomplished by sagit-
tal focusing through a double Si 111 crystal monochromator. A
vertical slit placed before the monochromator was set at about
1 mm to define the energy resolution. A 0.3 mm collimator
was used. The NSLS source was operated at 2.5 GeV with cur-
rents starting at approximately 240 mA. Three wavelengths
were selected to maximize dispersive and Bijvoet signals based
on the X-ray absorption spectrum for the derivatized crystal
near the Lin mercury edge, X1=1.0093 A (edge), k2 =1.0062 A
(peak) and X3=0.99188 A (remote). Five crystals were used to
collect data to Bragg spacings of 2.3 A. Inverse beam geometry
was used to collect Bijvoet mates on sequential images at each
wavelength. Data were recorded on Fuji HRIII phosphor
imaging plates by oscillation photography and scanned on a
Fuji BAS 2000 scanner. Data were integrated using DENZO
[51] and then reduced using CCP4 programs ROTAVATA
and AGROVATA [50] for SIRAS phasing or modified
versions for MADSYS phasing. MADSYS programs developed
by Hendrickson were used to calculate phases as previously
described [52]. Data processing and phasing statistics are
presented in Tables 2 and 3.
Table 2. Data, phasing and refinement statistics.
Crystal Native Hg (ad) Hg (2) Hg (I) Hg (3)
Internal scaling
Resolution () 20-1.8 5(
Reflections
measured 63 951 2(
Unique reflections 27086 5
Completeness (%) 96.3
Rsym (%)* 3.8
outermost shell 19.4
Ranom (%) -
outermost shell -
Derivative scaling
Resolution (A) 3(
R(F) (%)* 
Heavy-atom
refinement
Resolution (A) 3(
Cullis RC
Phasing power#
Figure of merit 
Phase combination
Figure of merit 0.89
Refinement
Resolution (A) 10-1.8
No. of
reflections 27008 (23849)
R-factor* 0.197 (0.185)
R-freet 0.259
No. of solvent
molecules 125
Geometry
deviations
Bond distances 0.014 A
Bond angle
distances 0.032 A
)-3.0 20-2.3 20-2.3 20-2.3
)0921 51 204
5629 12 346
86.1 91.6
12.2 5.1
30.1 16.2
- 6.6
- 13.1
)-3.5 20-2.5
24.8 28.8
0-3.5
0.45
1.9
.46
51 339
12360
91.7
5.1
15.6
5.0
11.3
51 209
12374
91.8
6.4
19.9
6.9
15.4
20-2.5
0.57
1.9
0.58
Native and 2.5 mM mercuric acetate derivatized, Hg (l, 2,
X3), data were recorded on Fuji HRIII plates at HHMI beamline
X4A, National Synchrotron Light Source (NSLS). Hg (2) is the
peak wavelength data from the MAD experiment. Hg (ad) data
were collected on two Xuong-Hamlin area detectors operating
on a Rigaku RU 200 rotating anode source. Crystals collected on
the area detector were approximately 90x90x300 p.m3.
Statistics are not shown for area detector native data which were
of similar quality to the derivative area detector data. Crystals
used for data collection at NSLS were 150-200 txm in the
smallest dimension. *Rsym=I I-<I> /SI. Outermost shells for
scaling are as follows: Native (1.85-1.80 A), Hg (ad) (3.08-3.0 A)
and Hg (Xl, 2, 3) (2.36-2.30 A). Ranom=.11+-1-1/1.
*R(F)="I FpH-F ] /yI /Fp , where Fp and FPH are the structure
factor amplitudes for native and derivative data, respectively.
5Cullis R=1 I I FpH±+Fp I - I FHcalc I /x I FpH-Fp , where sums are
over all centric reflections and FHcalc is the calculated
heavy atom structure factor. Phasing power is defined as
<FH>/<E>, where <FH> is the mean structure factor amplitude of
the heavy atoms and <E> is the mean closure error.
**R-factor=ElFbs-Fcalc/lFobsl, where the sum is over all
reflections with F>0, and in parentheses all reflections with
F>3t. t tR-free as defined by Bronger [59].
Native data were collected at X=0.98 A from a single crystal at
NSLS, beamline X4A, to Bragg spacings of 1.8 A. SIRAS
phases were calculated using maximum likelihood methods
implemented in MLPHARE from the CCP4 suite of programs
[50]. Synchrotron data from the peak wavelength were used as
the derivative. Phasing derived from the area detector data to
3.5 A, MAD phasing to 3.0 A and SIRAS phasing to 2.5 A
were combined by summing ABCD coefficients with figure
of merit weighting [53]. SIRAS phasing derived from area
detector data was used primarily to complement missing
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low-resolution reflections in the synchrotron data. Electron-
density maps calculated from three different phase sets, com-
bined MAD and SIRAS, MAD, and SIRAS, were used for
interpretation. Features of these maps include carbonyl oxygen
density and unambiguous side-chain density for the majority of
the amino acid residues. The best electron-density map was
that calculated with the combined MAD and SIRAS phases
(see Fig. 1). An initial model was built using FRODO [54].
As a point of interest, it should be noted that selenomethionyl
(Se-Met)-substituted protein was prepared in a methionyl auxo-
trophic strain of E. coli as previously described [55]. Crystals
were grown under very similar conditions to the native protein
and found to diffract similarly. However, analysis of MAD data
collected at NSLS from these crystals indicated that the Se-Met
residues were all poorly ordered. We were not able to identify
locations for the Se atoms in either isomorphous difference or
anomalous difference Patterson maps using the MAD data but
were able to locate the Se atoms in difference Fouriers calcu-
lated at 5 A using the mercury derivative phasing. The Se-Met
data did not result in useful phasing information and were
therefore not included in the final phasing of the structure.
Initial refinement of the model was performed using X-PLOR
conjugate-gradient minimization [56] using 5.0-2.5 A data
(F>2u) and then extended to 1.8 A resolution. The starting
model had an R-value of 0.41. The refinement converged
with an R-value of 0.25 for the starting model. Following five
cycles of rebuilding with FRODO [54] and refinement in
X-PLOR, an R-value of 0.22 was obtained for the protein
model and 57 water molecules. The refinement has been com-
pleted with PROLSQ [57] as implemented in CCP4 [50]. The
model currently includes residues 24-274 and 125 water mole-
cules. Criteria for water selection were limited to peaks with
electron-density values of 0.4 e- A- 3 found in both Fo-F c maps
and 2Fo-Fc maps and that were within 3.4 A of an oxygen or
nitrogen atom in the model. In addition, a B-factor limit
of <60 A2 was used to select water molecules. The R-value,
including 10-1.8 A data with F>3cr, is 0.185, with rms bond
deviations of 0.014 A and rms angle distance deviations of
0.032 A (see Table 2). Evaluation of our model with
PROCHECK [50] reveals that 92% of the residues in our
model have (q,) values that fall within the most favorable
regions of a Ramachandran plot. The only non-glycine outlier
is Val223 (=56.3°,t=-103.2°), which is located in the type
II' turn in the polymerase active site. We have confirmed this
conformation for Val223, seen in our experimental electron-
density map (see Fig. 1), using simulated annealing omit map
procedures implemented in X-PLOR [56] including data from
10-1.8 A. Atomic positions for side-chain atoms have been
reliably assigned for residues 24-274 excluding a loop ( 4-3 5),
which includes residues 102-108 for which we have marginal
main-chain density. Side-chain atom positions for residues
102-108 were modeled using steric constraints enforced by the
loop and are not reliable. No electron density was observed for
residues 10-23 in this structure. Coordinates for the native
structure have been deposited with the Brookhaven Protein
Data Bank (entry code 1MML).
Metal ion complex
A complex with Mn 2+ was prepared by soaking a crystal
(0.15x0.15x0O.3 mm3) for 3 h in a synthetic mother liquor
containing 20 mM MnC12. Data were collected to 2.6 A reso-
lution on an R-axis II image plate detector mounted on an
RU 200 rotating anode generator at room temperature. The
more modest resolution of the metal ion complex data is a
direct result of soaking the crystals in the metal ion solutions.
We have collected native data from crystals of similar size on
the same detector to 2.0 A resolution. Data for the Mn2+ com-
plex were integrated with DENZO [51] and scaled with CCP4
programs [50]. 8332 reflections (89% of the unique data) were
measured from 20-2.6 A. The multiplicity of measured data is
2.1 and R-merge is 7.0%. The model was refined using
PROLSQ [57] to an R-value of 0.173. A single Mn2 + peak in
the active site was observed in the initial Fnat-FMn difference
Fourier maps and in our final Fo-F c difference Fourier maps
with a contour height of 10a. The overall rms shift of the
complex model compared with the native model is 0.55 A.
The metal site has not been satisfactorily refined at 2.6 A due
to the apparent anisotropic disorder. For this reason we do not
report exact coordination distances of ligands nor water coor-
dination to the metal site. We feel that higher resolution data
are required to satisfactorily complete this analysis but that the
significance and general conclusions are not compromised in
the 2.6 A report given here.
Modeling of template/primer and dNTP
We first superimposed the MMLV RT palm domain with that
of the HIV-1 RT-Fab-19/18mer oligonucleotide complex
[23] including residues shown in Table 1. This allowed us to
then superimpose model A-form DNA phosphorus coordinates
on the experimentally determined phosphorus positions for the
19/18mer. Superposition of our model phosphorus coordinates
on template phosphorus atoms 14-17 and primer phosphorus
atoms 2-5 resulted in an rmsd of 0.78 A in TOSS [38]. Ideal-
ized model A-form DNA with a six base overhang was created
in INSIGHT [39]. Parameters for the A-form DNA are the
standard A-form DNA duplex parameters with a helical rise of
2.56 A per residue and a twist angle of -32.7° . The single-
strand overhang was modeled as A-form DNA, with small
Table 3. MAD phasing statistics.
Observed diffraction ratios* Expected diffraction ratios Mean scattering factors
Edge Peak Remote Edge Peak Remote f'(e-) f"(e-)
(1.0093 A) (1.0062 A) (0.9992 A) (1.0093 A) (1.0062 A) (0.9992 A)
Edge 0.063 (0.032) 0.033 0.043 0.054 0.033 0.047 -23.00 7.0
Peak 0.086 (0.030) (0.034) 0.081 0.014 -14.40 10.50
Remote 0.085 (0.033) 0.076 -10.87 9.88
*Observed diffraction ratios=<A I F 12>1/2/< 1 F 12>1/2, where A I F I is the absolute value of the Bijvoet difference (diagonal elements)
or dispersive difference (off-diagonal elements). Diagonal elements in parentheses are for centric data. Observed values are
weighted means for 20-3.0 A data from five crystals.
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adjustments made in the cr and torsion angles to avoid con-
flict with the protein, using CHAIN [58].
We have modeled dNTP binding by superimposing phospho-
rus coordinates from the ternary rat polymerase 3 structure [8]
on the HIV-1 RT complex phosphorus coordinates using
TOSS [38], including only two template and two primer phos-
phorus atoms from each model due to differences in oligonu-
cleotide parameters in these structures. We then transformed
the rat polymerase oligonucleotide and ddCTP coordinates
and superimposed model dATP on ddCTP. We have used the
phosphate coordinates from the transformed ddCTP in our
model dATP.
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